Hub Tenant

Insparin Therapeutics, Inc.

Insparin Therapeutics is a biotechnology startup spun out of Texas Tech University that is developing first-in-class therapies for severe insulin resistance and related rare metabolic diseases.We are focused on advancing novel therapeutics designed to improve glucose control independent of insulin. Our mission is to transform the treatment landscape for patients with few or no effective options today, while also exploring broader applications in common metabolic conditions.

Website

Rohan Dhurandhar
rohan.dhurandhar@insparin.com